Results 141 to 150 of about 67,405 (197)

A clinician's perspective on yellow fever vaccine-associated neurotropic disease. [PDF]

J Travel Med, 2020
Lecomte E, Laureys G, Verbeke F, Domingo Carrasco C, Van Esbroeck M, Huits R.   +5 more
europepmc   +1 more source

Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial. [PDF]

Vaccine
Osei I, Schmidt-Chanasit J, Licciardi PV, Secka O, D'Alessandro U, Salaudeen R, Sarwar G, Clarke E, Mohammed NI, Nguyen C, Greenwood B, Jansen S, Mackenzie GA.   +12 more
europepmc   +1 more source

Electron transport chain capacity expands yellow fever vaccine immunogenicity. [PDF]

EMBO Mol Med
Mok DZ, Tng DJ, Yee JX, Chew VS, Tham CY, Ooi JS, Tan HC, Zhang SL, Lin LZ, Ng WC, Jeeva LL, Murugayee R, Goh KK, Lim TP, Cui L, Cheung YB, Ong EZ, Chan KR, Ooi EE, Low JG.   +19 more
europepmc   +1 more source

Immune response induced by standard and fractional doses of 17DD yellow fever vaccine. [PDF]

NPJ Vaccines
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML, Collaborative Group for Studies of Yellow Fever Vaccine, Martins-Filho OA, do Antonelli LRDV.   +29 more
europepmc   +1 more source

Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV-ANRS 12403. [PDF]

Vaccines (Basel)
Caetano DG, Toledo TS, de Lima ACS, Giacoia-Gripp CBW, de Almeida DV, de Lima SMB, Azevedo AS, Morata M, Grinsztejn B, Cardoso SW, da Costa MD, Brandão LGP, Bispo de Filippis AM, Scott-Algara D, Coelho LE, Côrtes FH.   +15 more
europepmc   +1 more source

Fatal viscerotropic and neurotropic disease after yellow fever vaccine: a rare manifestation leading to diagnosis of severe combined immunodeficiency in an infant. [PDF]

Rev Inst Med Trop Sao Paulo
Vieira LJT, Goebel GA, Barcelos Y, Cunha LO, Santos LTM, Romanelli RMC, Minafra FG, Carvalho AL, Carvalho LFA, Diniz LMO.   +9 more
europepmc   +1 more source

Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trial. [PDF]

EBioMedicine
Pagnon A, Carre C, Aguirre M, Chautard E, Gimenez S, Raynal F, Feroldi E, Scott P, Modjarrad K, Vangelisti M, Mantel N.   +10 more
europepmc   +1 more source

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan. [PDF]

Trials
Mackenzie GA, Osei I, Salaudeen R, Licciardi PV, Greenwood B, Mulholland K, Nguyen C.   +6 more
europepmc   +1 more source

Invasive aspergillosis complication in yellow fever vaccine induced viscerotropic disease. [PDF]

Med Mycol Case Rep, 2020
Breda GL, Domino NR, de Noronha L, Duarte Dos Santos CN, Zanluca C, Kruger RS, Queiroz-Telles F, Raboni SM.   +7 more
europepmc   +1 more source

Yellow Fever Vaccination [PDF]

American Journal of Public Health and the Nations Health, 1956
openaire   +1 more source